Eizirik D L, Welsh N, Sener A, Malaisse W J
Department of Medical Cell Biology, Uppsala University, Sweden.
Biochem Med Metab Biol. 1994 Oct;53(1):34-45. doi: 10.1006/bmmb.1994.1055.
The monomethyl ester of succinic acid (SME) was recently found to protect pancreatic islet B-cells against the impairment of glucose-stimulated insulin release caused by either glucopenia or starvation. The possible metabolic determinants of such a protective action are now scrutinized. After 180 min preincubation at 2.8 mM D-glucose in the presence of SME (10 mM), the oxidation of D-[U-14C]glucose, relative to either the utilization of D-[5-3H]glucose or the generation of 14C-labeled acidic metabolites, was higher than that after preincubation in the absence of SME and became close to that otherwise found after preincubation at 16.7 mM D-glucose. Likewise, after 3 days of culture at a low concentration of D-glucose (2.8 mM), the presence of SME in the culture medium tended to increase the subsequent oxidation of D-[6-14C]glucose and utilization of D-[5-3H]glucose. These two variables increased as a function of the concentration of D-glucose in the culture medium, this coinciding with a modest increase in hexokinase activity and a more pronounced increase in glucokinase activity. The presence of SME in the culture medium failed, however, to exert any obvious effect upon the respiration of the islets, suggesting that the protective action of the ester against glucopenia may also involve variables distinct from the metabolism of either endogenous or exogenous nutrients. Likewise, the fact that SME infusion to starved rats prevents the impairment of glucose-induced insulin release otherwise attributable to starvation may involve enzymatic determinants, such as a less severe decrease in glucokinase activity, metabolic variables, such as a greater relative increase in D-[U-14C]glucose oxidation relative to D-[5-3H]glucose utilization in response to a rise in extracellular D-glucose concentration, and other factors yet to be identified that participate in the secretory sequence at a site distal to those metabolic events triggered by D-glucose in the islet cells.
最近发现,琥珀酸单甲酯(SME)可保护胰岛β细胞,使其免受低血糖或饥饿所致的葡萄糖刺激胰岛素释放功能损害。目前正在仔细研究这种保护作用可能的代谢决定因素。在2.8 mM D - 葡萄糖存在下(10 mM SME)预孵育180分钟后,相对于D - [5 - 3H]葡萄糖的利用或14C标记酸性代谢产物的生成,D - [U - 14C]葡萄糖的氧化高于无SME预孵育后的氧化水平,且接近在16.7 mM D - 葡萄糖预孵育后的水平。同样,在低浓度D - 葡萄糖(2.8 mM)中培养3天后,培养基中存在SME往往会增加随后D - [6 - 14C]葡萄糖的氧化和D - [5 - 3H]葡萄糖的利用。这两个变量随培养基中D - 葡萄糖浓度的变化而增加,这与己糖激酶活性适度增加以及葡萄糖激酶活性更显著增加相吻合。然而,培养基中存在SME对胰岛的呼吸未产生任何明显影响,这表明该酯对低血糖的保护作用可能还涉及与内源性或外源性营养物质代谢不同的变量。同样,向饥饿大鼠输注SME可防止饥饿所致的葡萄糖诱导胰岛素释放功能损害,这可能涉及酶学决定因素,如葡萄糖激酶活性下降程度较轻;代谢变量,如细胞外D - 葡萄糖浓度升高时,D - [U - 14C]葡萄糖氧化相对于D - [5 - 3H]葡萄糖利用的相对增加幅度更大;以及其他尚未确定的因素,这些因素在胰岛细胞中由D - 葡萄糖触发的代谢事件远端的位点参与分泌过程。